Elsevier

Matrix Biology

Volume 16, Issue 9, March 1998, Pages 529-540
Matrix Biology

Minireview
Toward understanding S0X9 function in chondrocyte differentiation

https://doi.org/10.1016/S0945-053X(98)90065-8Get rights and content

Abstract

The transcription factors that trigger the determinative switch to chondrocyte differentiation in mesenchymal cells are still unknown. In humans, mutations in the gene for SOX9, a transcription factor with a DNA-binding domain similar to that of the mammalian testis-determining factor SRY, cause campomelic dysplasia, a severe dwarfism syndrome which affects all cartilage-derived structures. During mouse embryonic development, the Sox9 gene becomes active in all prechondrocytic mesenchymal condensations, and at later stages its expression is maintained at high levels in fully differentiated chondrocytes. A chondrocyte-specific enhancer in the gene for collagen type II (Col2a1), a characteristic marker of chondrocytes, is a direct target for SOX9, and ectopic expression of SOX9 in transgenic mouse embryos is sufficient to activate the endogenous Col2a1 gene in some tissues. These data suggest that SOX9 could have a major role in chondrogenesis. Studies are in progress to identify other target genes for SOX9 in chondrocytes and also other transcription factors that are believed to cooperate with SOX9 in the activation of chondrocyte-specific genes. Defining SOX9 function and the mechanisms that regulate SOX9 gene expression should contribute to a better understanding of chondrocyte differentiation.

References (50)

  • A. Rawls et al.

    MyoD meets its maker

    Cell

    (1997)
  • G.A. Rodan et al.

    The missing bone

    Cell

    (1997)
  • P. Tontonoz et al.

    Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor

    Cell

    (1994)
  • T. Wagner et al.

    Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX-9

    Cell

    (1994)
  • M.K. Webster et al.

    FGFR activation in skeletal disorders: too much of a good thing

    TIG

    (1997)
  • M.H. Werner et al.

    Molecular basis of human 46X,Y sex reversal revealed from the three-dimensional solution structure of the human SRY-DNA complex

    Cell

    (1995)
  • M.H. Werner et al.

    Molecular determinants of mammalian sex

    TIBS

    (1996)
  • A.D. Baxevanis et al.

    The HMG-1 box protein family: classification and functional relationships

    Nucleic Acids Res.

    (1995)
  • D.M. Bell et al.

    SOX9 directly regulates the type-II collagen gene

    Nat. Genet.

    (1997)
  • F.J. Cameron et al.

    A novel germ line mutation in SOX9 causes familial campomelic dysplasia and sex reversal

    Hum. Mol. Genet.

    (1996)
  • K.S.E. Cheah et al.

    Expression of the mouse α1(II) collagen gene is not restricted to cartilage during development

    Development

    (1991)
  • F. Connor et al.

    DNA binding and bending properties of the post-meiotically expressed Sry-related protein Sox-5

    Nucleic Acids Res.

    (1994)
  • A. Erlabacher et al.

    Toward a molecular understanding of skeletal development

    Cell

    (1995)
  • J.W. Foster et al.

    Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene

    Nature

    (1994)
  • K. Giese et al.

    Assembly and function of a TCRa enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions

    Genes Dev.

    (1995)
  • Cited by (0)

    This minireview is the first of a series, edited by Klaus von der Mark, devoted to cartilage differentiation.

    View full text